TrialBritish journal of clinical pharmacology2026

A phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of PF-07261271 in healthy participants.

Srividya Neelakantan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.